CURRENT CONCEPT OF HUMAN HERPESVIRUS TYPE 6 INFECTION
https://doi.org/10.20514/2226-6704-2016-6-1-13-19
Abstract
Human herpes virus type 6 infection is widely distributed. It is extensively studied recent years due to the imperfection of diagnostics, as well as participa- tion in the formation of chronic somatic pathology. According to the international classification 2012, the human herpes virus 6A and human herpesvirus 6B are separate taxonomic units, which vary in sequence of nucleotides, structure, epidemiology, age of infection, the characteristics of flow, sensitivity to therapy. The review contains current data on clinical manifestations, methods of diagnosis and therapy of human herpes virus 6 infectionat different ages.
About the Authors
E. V. Melehina
Clinical department of infectious diseases, Federal Budget Institution of Science «Central Research Institute of Epidemiology», Moscow, Russian Federation
Russian Federation
Russian Federation
A. D. Muzyka
Clinical department of infectious diseases, Federal Budget Institution of Science «Central Research Institute of Epidemiology», Moscow, Russian Federation
Department of hospital Pediatrics No 1 pediatric faculty, N.I.Pirogov Russian National Research Medical University, Moscow, Russian Federation
Russian Federation
Russian Federation
M. Ju. Kalugina
Clinical department of infectious diseases, Federal Budget Institution of Science «Central Research Institute of Epidemiology», Moscow, Russian Federation
Russian Federation
Russian Federation
A. V. Gorelov
Clinical department of infectious diseases, Federal Budget Institution of Science «Central Research Institute of Epidemiology», Moscow, Russian Federation
Russian Federation
Russian Federation
O. L. Chugunova
Department of hospital Pediatrics No 1 pediatric faculty, N.I.Pirogov Russian National Research Medical University, Moscow, Russian Federation
Russian Federation
Russian Federation
References
1. Vashura L.V., Savenkova M.S. Herpes 6 type (epidemiology, diagnostics, clinical presentation). Lechashhij vrach. 2014; 11: 18-25. (In Russian).
2. Isakov V.A., Arhipova E.I., Isakov D.V. Human herpesvirus infections: a guide for physicians. Speclit. 2013; 670 p. (In Russian).
3. Kalugina M.Ju. Epidemiological characteristics of infections caused by herpes virus 6: diss. kand. biol. nauk. M. 2009; 169 p. (In Russian).
4. Melehina E.V., Chugunova O.L., Muzyka A.D. et al. Role of herpesvirus infections in the formation of pathology in children. Сharacteristic of course, diagnosis and treatment infections associated with the human herpes virus 6 in children. Metodicheskie rekomendacii. M. 2014; 50 p. (In Russian).
5. Nikol'skij M.A. Clinical variants of primary infection caused by the human herpes viruses 6 and 7, in children of early age. Pediatrija. 2008; 87(4): 52-55. (In Russian).
6. Nikol'skij M.A., Golubcova V.S. Chromosomal-integrated human herpes virus 6. Infekcija i immunitet. 2015; 5(1): 7–14. (In Russian).
7. Novosad E.V. Infectious mononucleosis, associated with herpes virus type 6: dis. kand. med. nauk. M. 2010; 127 p. (In Russian).
8. Romancov M.G., Ershov F.I. Chasto bolejushhie deti. Sovremennaja farmakoterapija. M.: GJeOTAR-Media. 2006; 190. (In Russian).
9. Agut H., Bonnafous P., Gautheret-Dejean A. Laboratory and clinical aspects of human herpesvirus 6 infections. Clin.Microbiol.Rev. 2015; 28(2): 313-335.
10. Arbuckle J.H., Medveczky P.G. The molecular biology of human herpesvirus-6 latency and telomere integration. Microbes.Infect. 2011; 13(8-9): 731–741.
11. Bounaadja L., Piret J., Goyette N. et al. Analysis of HHV-6 mutations in solid organ transplant recipients at the onset of cytomegalovirus disease and following treatment with intravenous ganciclovir or oral valganciclovir. J. Clin. Virol. 2013; 58(1): 279-82.
12. Caserta M.T., Hall C.B., Canfield R.L. et al. Early developmental outcomes of children with congenital HHV-6 infection. Pediatrics. 2014; 134(6): 1111-1118.
13. Crosslin D.R.,Carrell D. S., Amber A. Burt. et al. Genetic variation in the HLA region is associated with susceptibility to herpes zoster. Genes and Immunity. 2015; 16: 1–7.
14. Hall C.B., Caserta M.T., Schnabel K.C. et al. Transplacental congenital human herpesvirus 6 infection caused by maternal chromosomally integrated virus. J Infect Dis. 2010; 201(4): 505-507.
15. Hall C.B., Caserta M.T., Schnabel K.C. et al. Congenital infections with human herpesvirus 6 (HHV6) and human herpesvirus 7 (HHV7). J Pediatr. 2004; 145(4): 472-7.
16. Kainth M.K., Fisher S.G., Fernandez D. et al. Understanding the association between chromosomally integrated human herpesvirus 6 and HIV disease: a cross-sectional study. F1000Res. 2013; 2: 269.
17. Kaufer B.B., Flamand L. Chromosomally integrated HHV-6: impact on virus, cell and organismal biology. Curr. Opin. Virol. 2014; 9: 111–118.
18. Kazlauskas D., Venclovas Č. Herpesviral helicase-primase subunit UL8 is inactivated B-family polymerase. Bioinformatics. 2014; 30(15): 2093–2097.
19. Ketsueki R. Salt-wasting nephropathy induced by foscarnet treatment for HHV-6 encephalitis in a hematopoietic stem cell transplant. 2008; 49(1): 40-45.
20. Lanari M., Papa I., Venturi V. et al. Congenital infection with human herpesvirus 6 variant B associated with neonatal seizures and poor neurological outcome. J Med Virol. 2003; 70(4): 628-632.
21. LimH. K., Seppänen M., Hautala T. et al. TLR3 deficiency in herpes simplex encephalitis: High allelic heterogeneity and recurrence risk. Neurology. 2014; 83 (21): 1888-1897.
22. Muylaert I., Zhao Z., Per Elias. UL52 Primase Interactions in the Herpes Simplex Virus 1 Helicase-Primase Are Affected by Antiviral Compounds and Mutations Causing Drug Resistance. The Journal Of Biological Chemistry. 2014; 289(47): 32583–32592.
23. Piret J., Boivin G. Antiviral drug resistance in herpesviruses other than cytomegalovirus. Rev. Med. Virol. 2014; 24: 186–218.
24. Pohlmann C., Johannes Schetelig, Ulrike Reuner et al. Cidofovir and Foscarnet for Treatmentof Human Herpesvirus 6 Encephalitisin a Neutropenic Stem Cell Transplant Recipient/ CID 2007; 44: e118-e120.
25. Rdos P., Dde Ferreira, Nóbrega F. et al. Current status of herpesvirus identification in the oral cavity of HIV-infected children. Rev. Soc. Bras. Med. Trop. 2013; 46(1): 15-19.
26. Shiohara T., Iijima M., Ikezawa Z. et al. The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations. Br. J. Dermatol. 2007; 156: 1083–1084.
27. Subhajit Biswas, Hugh J Field, Madingley Road. Pointer Herpes simplex virus helicase–primase inhibitors: recent findings from the study of drug resistance mutations. Antiviral Chemistry & Chemotherapy. 2008; 19: 1–6
28. Veeder B., Hempelmann Т. A febrile exanthem occurring in childhood (exanthem subitum). JAMA 1921; 77: 1787-1789.
29. Yamanishi K., Okuno Т., Shiraki К. et al. Identification of human herpesvirus 6 as a casual agent for exanthema subitum. Lancet. 1988; 1: 1065.
30. Yoshimichi H., Atsuo I. Minimal Dose Interferon Suppository Treatment Suppresses Viral Replication with Platelet Counts and Serum Albumin Levels Increased in Chronically Hepatitis C Virus-Infected Patients: A Phase 1b, Placebo-Controlled, Randomized Study. Journal of interferon & cytokine research. 2014; 34(2): 111-116.
31. Zahorsky J. Roseola infantum. JAMA. 1913; 61: 446-450.
Review
For citations:
Melehina E.V., Muzyka A.D., Kalugina M.J., Gorelov A.V., Chugunova O.L. CURRENT CONCEPT OF HUMAN HERPESVIRUS TYPE 6 INFECTION. The Russian Archives of Internal Medicine. 2016;6(1):13-19. (In Russ.) https://doi.org/10.20514/2226-6704-2016-6-1-13-19
Views:
1786
Email this article 